胡丽娟 - 四川大学 - 华西基础医学与法医学院

个人简介

胡丽娟，副教授，硕士生导师。生物学专业学士，细胞生物学与分子生物学专业硕士，生物医学工程专业博士。免疫学专业硕士生导师，英国牛津大学名誉校友，加拿大多伦多大学/病童医院发育与干细胞生物学项目访问学者。主要科研成就：主持国家基础科学人才培养基金能力提高项目子课题1项、四川省科技厅重点研发项目1项、四川大学青年科学研究基金1项、四川大学技术服务横向课题2项；主研国家自然科学基金8项、省部级基金3项、校级项目6项。在国内外核心刊物发表论文30多篇，其中SCI收录12篇。作为主编编写一部免疫学教材；作为编者参与编写9部免疫学教材。Hybridoma, Oncology letters等杂志审稿人。主要获奖情况：基础医学与法医学院第二届中青年教师英语讲课比赛二等奖；四川大学青年骨干教师奖；华西临床医学院“十佳”优秀教师奖；四川大学本科教学“课堂教学质量优秀奖”；全国第二届微课教学比赛二等奖。代表性著作包括： (1)医学免疫学（普通高等教育“十二五”规划教材；全国普通高等教育基础医学类系列教材）,科学出版社, 2015.5（第二版）和2013.12（第一版）. (2)实用口腔免疫学与技术（本科与研究生教材）,人民卫生出版社. 2010.10. (3)医学免疫学（本科教材）,四川大学出版社, 2010.10 . (4)医学实验技术的原理与选择（卫生部十一五规划教材；全国高等医药教材建设研究会规划教材；全国高等学校医学研究生规划教材），人民卫生出版社. 2008.9 . (5)医学免疫学（高校创新教材），人民卫生出版社. 2007.7. (6)医学免疫学纲要（研究生系列教材），四川大学出版社, 2007.5. (7)医学免疫学（医学必修课考试辅导教材），科学技术文献出版. 2005.7. (8)医学免疫学实验指导（西部院校实验教材），人卫出版社。待出版。

研究领域

单克隆抗体的制备与应用；细胞因子与疾病；免疫细胞与分子在疾病治疗中的作用与机制研究

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

(1)Cross-presentation of Exogenous Antigens. Transfus Clin Biol. 2019, 26(4):346-351. (2)Diagnosis of hepatocellular carcinoma using a novel anti‑glycocholic acid monoclonal antibody‑based method. ONCOLOGY LETTERS. 2019, 17: 3103-3112. (3)Low molecular weight heparin might benefit nephrotic remission in sensitive nephrotic syndrome by inhibiting elastase activity. Molecular Medicine Reports. 2017, 16: 8613-8618. (4)High expression of Special AT-rich sequence binding protein-1 predicts esophageal squamous cell carcinoma relapse and poor prognosis. Oncology letters. 2017,14(6): 7455-7460. (5)CD300LG improves the cytotoxic activity of CIK. Cent Eur J Immunol 2017; 42 (2): 117-122. (6)Respiratory Syncytial Virus Aggravates Renal Injury through Cytokines and Direct Renal Injury. Frontier in cellular and infection microbiology. 2016.6:112 (7)Expression depression of CD300LG-γin human pulmonary carcinoma. Monoclon Antib Immunodiagn Immunothe. 2016, 35(2): 94-99. (8)A Novel Monoclonal Antibody Against Human DAB2IP. Monoclon Antib Immunodiagn Immunothe. 2015,34(4): 251-256. (9)Tranilast Prevents the Progression of Chronic Cyclosporine Nephrotoxicity Through Regulation of Transforming Growth Factor β/Smad Pathways. Transplantation Proceedings. 2011,43:1985-1988. (10)Tranilast Attenuates Chronic Cyclosporine A Nephrotoxicity in Rats. Transplantation Proceedings. 2009,41(10):4373-4375. (11)RACK1, a Novel hPER1-Interacting Protein. Journal of Molecular Neuroscience. 2006,29:55-63. (12)Association of single nucleotide polymorphisms of CSPG2 and HSPG2 genes with intracranial aneurysm in ethnic Han Chinese population.Chin J Med Genet. 2013, 30(2): 218-221. (13)Effects of tranilast on TGF-β/Smad pathways in rats with chronic cyclosporine A nephrotoxicity. Journal of Immunology. 2009, 25(3): 297-300. [In Chinese] (14)The Effects of rTMS on the CPP expression of morphine dependence mice. Journal of Sichuan University (Nation Science Edition). 2009, 46(6)1828-1832. [In Chinese] (15)Research progress of repetitive transcranial magnetic stimulation (rTMS) in the treatment of addiction: a review. Journal of Sichuan University (Nation Science Edition). 2009, 46(suppl2): 244-250.[In Chinese] (16)The effect of tranilast on AngⅡ and ET-1 in the rats with chronic cyclosporine A nephrotoxicity.Journal of Sichuan University (Nation Science Edition). 2008, 45(2): 426-430. [In Chinese] (17)Selection of the Novel Proteins Interacting with hPER1 in Blood. Journal of Sichuan University (Nation Science Edition). 2006,43(5): 1127-1131. [In Chinese]